← SynDRA
PALIPERIDONE PALMITATE
SynDRA canonical compound SYN0032900 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DRD2 |
|---|
| Mechanism of action | dopamine receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- dopamine receptor antagonist
Drug classes
- Atypical Antipsychotic
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Dopamine Agents
- Dopamine Antagonists
- Dopamine D2 Receptor Antagonists
- Neurotransmitter Agents
- Psychotropic Drugs
- Serotonin 5-HT2 Receptor Antagonists
- Serotonin Agents
- Serotonin Antagonists
Cross-references
Synonyms
- RO92670
- invega sustenna
- Palperidone palmitate
- JNS-010
- JNS010
- R-092670
- R092670
- RO-92670
- Byannli (previously paliperidone janssen-cilag international)
- Erzofri
- Invega sustenna
- Invega trinza
- Niapelf
- Paliperidone janssen
- Trevicta (previously paliperidone janssen)
- Xeplion
- JNS 010
- Invega Sustenna
- PALIPERIDONE JANSSEN
- ERZOFRI
- Invega Trinza
- PP3M
- 9-Hydroxyrisperidone Palmitate
- R8P8USM8FR
- xeplion
- Ro-92670
- Sustenna, Invega
- INVEGA HAFYERA
- Palmitate, Paliperidone
- Erzofri extended-release
- RefChem:56593
- CHEBI:83807
- Paliperidone Palmitate [USAN]
- MFCD24386477
- Trinza
- UNII-R8P8USM8FR
- C39H57FN4O4
Look up PALIPERIDONE PALMITATE in the interactive SynDRA portal →